C4 Therapeutics Target Price

C4 Therapeutics target price — quarterly history, peer benchmarks, and growth trends.

Get informed when a big investor buys or sells

+ Follow

Share Price

$4.08

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-02-26	BarclaysEtzer Darout	$7	71.6% upside
2025-12-17	Barclays	$5	22.5% upside
2025-09-23	Wells FargoDerek Archila	$10	145.1% upside
2025-09-22	BarclaysEtzer Darout	$10	145.1% upside
2025-09-16	Barclays	$8	96.1% upside
2025-09-15	StephensSudan Loganathan	$6	47.1% upside
2024-12-19	Wells FargoDerek Archila	$12	194.1% upside
2024-09-19	BMO CapitalEtzer Darout	$20	390.2% upside
2023-01-03	Wells Fargo	$9	120.6% upside
2022-04-28	Credit Suisse	$10	145.1% upside
2022-04-11	Bank of America SecuritiesChi Fong	$15	267.6% upside

C4 Therapeutics (CCCC) FAQ

Stockcircle tracks target price for C4 Therapeutics (CCCC), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for C4 Therapeutics's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main CCCC overview so you can move from this figure to the surrounding analysis quickly.